I now have substantial content from multiple textbooks. Let me compile a comprehensive response.
Chronic Pharyngitis, Chronic Tonsillitis, Adenoids, and Tumors of the Pharynx
1. Chronic Pharyngitis
Definition & Forms
Chronic pharyngitis is persistent inflammation of the pharyngeal mucosa lasting beyond the acute phase. It is subdivided into:
- Chronic catarrhal (simple) pharyngitis — mucosal congestion with mild secretion
- Chronic hypertrophic pharyngitis — thickening of the mucosa with lymphoid follicle prominence on the posterior pharyngeal wall ("granular pharyngitis")
- Chronic atrophic pharyngitis — atrophy of mucosa and glands, dryness, crusting
Etiology
- Repeated episodes of acute pharyngitis (especially streptococcal, viral)
- Persistent irritants: smoking, alcohol, dust, chemical fumes, dry air
- Laryngopharyngeal reflux (LPR) — a major cause of chronic posterior pharyngitis; gastroesophageal reflux leads to intermittent hoarseness, chronic cough, postnasal drip, "globus" sensation, halitosis, and brackish/acid taste
- Mouth breathing (from nasal obstruction/adenoid hypertrophy)
- Chronic sinusitis with postnasal drip
- Systemic conditions: diabetes, renal failure, immune deficiency
Clinical Features
- Persistent sore throat, tickling/rawness, dryness
- Sense of foreign body (globus)
- Mucus accumulation requiring frequent clearing
- Halitosis
- On examination: pharyngeal erythema, visible lymphoid granules on posterior wall (hypertrophic form), pale/dry atrophic mucosa (atrophic form)
- Laryngoscopy in LPR: posterior laryngitis, swollen/erythematous arytenoids, interarytenoid edema, mucosal thickening
Treatment
- Eliminate causative irritants (smoking cessation, alcohol reduction)
- LPR: dietary changes, behavioral modification (head-of-bed elevation), proton pump inhibitor (PPI) trial for up to 3 months; if no response in 3 months or warning signs (ear pain, trismus, odynophagia), laryngoscopy is mandatory to exclude malignancy
- Gargling, mucosal lubricants, saline irrigation
- Address underlying conditions (chronic sinusitis, nasal obstruction)
— Goldman-Cecil Medicine, p. 3860
2. Chronic Tonsillitis
Pathology
Patients develop deep tonsillar crypts that accumulate debris (food, sloughed mucosa), providing an ideal environment for bacterial growth — especially anaerobes and Actinomyces (a commensal of the oral cavity and oropharynx). This creates a low-grade persistent infection.
Key pathological features:
- Crypt accumulation of caseous/purulent debris ("tonsilliths" or tonsilloliths)
- Biofilm formation within crypts
- Chronic lymphoid inflammation
Clinical Features
- Recurrent or persistent sore throat
- Tonsilliths: whitish/yellow semisolid debris on or emanating from the tonsils, often with foul taste and odor
- Halitosis — characteristic and often the primary complaint
- Occasionally cervical lymphadenopathy
- History of recurrent acute tonsillitis ± peritonsillar abscess
Bacteriology
The microbial flora is polymicrobial, dominated by:
- Group A β-hemolytic Streptococcus (GABHS)
- Staphylococcus aureus, H. influenzae, S. pneumoniae
- Anaerobes (Bacteroides, Fusobacterium)
- Actinomyces — signals deep chronicity and antibiotic resistance
Diagnosis
- Clinical: characteristic history + inspection of tonsillar crypts
- The presence of Actinomyces on culture is indicative of chronic infection requiring surgery
Treatment
Conservative:
- Frequent gargling with hydrogen peroxide mouthwash
- Manual expression of debris from tonsillar crypts
- Long-term antibiotics:
- Amoxicillin 500 mg three times daily for 21 days, or
- Clindamycin 300 mg orally three times daily for 21 days
Surgical (Tonsillectomy) — indications:
- Presence of Actinomyces (long-term antibiotics unlikely effective)
- Multiple episodes of acute tonsillitis (especially with peritonsillar abscess)
- Obstructive tonsillar hypertrophy
- Adenotonsillectomy reduces episodes of sore throat and days with sore throat in children in the first year post-surgery; benefit in adults is less certain — many improve spontaneously, so surgical risk (hemorrhage, pain — more severe in adults) must be weighed carefully
— Goldman-Cecil Medicine, pp. 3849–3850
3. Adenoids (Adenoid Hypertrophy / Chronic Adenoiditis)
Anatomy
The adenoids (pharyngeal tonsil) are lymphoid tissue located on the posterior wall of the nasopharynx. They form part of Waldeyer's ring along with the palatine and lingual tonsils.
Adenoid Hypertrophy — Clinical Significance
Enlarged adenoids obstruct the nasopharynx and Eustachian tube orifices, causing:
- Nasal obstruction → mouth breathing → "adenoid facies" (elongated face, open mouth, high-arched palate, dental malocclusion)
- Chronic otitis media with effusion (glue ear) / recurrent acute otitis media — from Eustachian tube dysfunction
- Chronic sinusitis (CRS) — adenoids are in close proximity to the paranasal sinuses
Adenoids as a Bacterial Reservoir in CRS
Cummings Otolaryngology emphasizes that adenoids serve as a major reservoir for bacteria:
- 88–99% of adenoid mucosal surface in children with CRS is covered by dense biofilm (vs. only 0–6.5% in sleep apnea controls)
- Hypertrophied adenoids share similar bacteriology with the middle meatuses in children with chronic/recurrent sinusitis
- Core adenoid cultures have a positive predictive value for forecasting middle meatal cultures
- Common organisms: alpha-hemolytic streptococci, S. aureus, S. pneumoniae, H. influenzae, M. catarrhalis; anaerobes are infrequent
- Importantly, the contribution of adenoids to CRS may relate more to their bacterial reservoir function than to their physical size alone
Inflammatory Changes
- Older children with CRS: eosinophils and CD4+ lymphocytes predominant
- Younger children: lymphocytes and neutrophils more prominent; less epithelial disruption
- Submucosal glandular hyperplasia is the characteristic phenotype in pediatric CRS
Treatment
- Adenoidectomy is effective in resolving CRS symptoms in a subset of children, particularly those resistant to antibiotic therapy
- This benefit is thought to be due to elimination of the biofilm reservoir rather than just physical deobstruction
- Adenoidectomy is also performed for obstructive sleep apnea and recurrent otitis media
— Cummings Otolaryngology, pp. 3784–3785
4. Tumors of the Pharynx
Classification by Site
The pharynx is divided into:
- Nasopharynx (epipharynx) — above the soft palate
- Oropharynx — soft palate, base of tongue, tonsils, posterior pharyngeal wall
- Hypopharynx (laryngopharynx) — pyriform sinuses, posterior pharyngeal wall, post-cricoid region
The vast majority are squamous cell carcinomas (SCC), but histology varies by subsite.
Signs and Symptoms
Early:
- Nodule or ulcerative lesion of the mucosa
- Odynophagia, dysphagia
- Otalgia (referred via CN IX/X)
- Eustachian tube dysfunction
- Hoarseness lasting >2 weeks
Advanced:
- Cranial nerve dysfunction
- Nasal obstruction (nasopharynx)
- Severe dysphagia, hemoptysis, respiratory distress
- Unintentional weight loss
HPV-related oropharyngeal SCC (increasingly common):
- Often presents with cervical lymphadenopathy with a small or inapparent primary tumor
- p16-positive (HPV surrogate marker)
- Better prognosis than non-HPV cancers
Non-HPV cancers: presence of positive lymph nodes decreases chance of cure by ~50%.
Diagnosis & Imaging
- Tissue biopsy of primary site with histologic evaluation; FNA cytology of enlarged cervical lymph nodes
- p16 immunostaining to determine HPV association (critical for staging/prognosis)
- CT scan or contrast-enhanced MRI of neck soft tissues: defines primary tumor size, location, anatomical structure involvement, and lymph node status
- PET-CT: evaluation for distant metastases and occult primary
Staging (TNM)
Non-HPV oropharyngeal / hypopharyngeal SCC (p16-negative):
| T Category | N0 | N1 | N2a–c | N3 |
|---|
| T0 | I | III | IVA | IVB |
| T1 | II | III | IVA | IVB |
| T2 | III | III | IVA | IVB |
| T3 | IVA | IVA | IVA | IVB |
| T4 | IVB | IVB | IVB | IVB |
HPV-associated oropharyngeal SCC (p16-positive): Significantly better prognosis — separate staging system where even N2–N3 disease may be Stage II–III (max Stage III).
Treatment
Principles of management (KJ Lee's Essential Otolaryngology):
- Surgery (transoral robotic surgery [TORS], transoral laser microsurgery, open approaches) ± reconstruction
- Radiation therapy (definitive or adjuvant)
- Concurrent chemoradiation — standard for locally advanced disease (Stage III–IVA/B)
- Chemotherapy agents: cisplatin is the most common concurrent agent; carboplatin + 5-FU or taxane-based regimens also used
- Targeted therapy: Cetuximab (anti-EGFR) used in patients who cannot tolerate cisplatin
- Immunotherapy (pembrolizumab, nivolumab): approved for recurrent/metastatic disease refractory to platinum-based chemotherapy
By subsite:
| Subsite | Key Points |
|---|
| Nasopharyngeal carcinoma (NPC) | Associated with EBV; endemic in Southeast Asia/North Africa; radiosensitive — primary treatment is radiation ± chemotherapy; surgery rarely used |
| Oropharyngeal SCC | HPV+ cases (tonsil/base of tongue) have excellent response to chemoradiation; de-escalation trials ongoing; TORS increasingly used |
| Hypopharyngeal SCC | Poor prognosis; typically advanced at presentation; larynx preservation with chemoradiation attempted when possible |
Surgical considerations:
- Neck dissection for clinically or radiologically positive nodes
- Reconstruction: free flap (radial forearm, anterolateral thigh) for large defects
- For HPV+ oropharyngeal cancer: organ preservation protocols preferred given excellent outcomes
— K.J. Lee's Essential Otolaryngology, pp. 842–843
Key Comparisons Summary
| Feature | Chronic Pharyngitis | Chronic Tonsillitis | Adenoid Hypertrophy | Pharyngeal Tumors |
|---|
| Main cause | Irritants, LPR, recurrent infection | Recurrent infection, cryptic flora, biofilm | Lymphoid hyperplasia, biofilm reservoir | SCC (tobacco/alcohol, HPV, EBV for NPC) |
| Key organism | Mixed/viral | Anaerobes, Actinomyces | S. aureus, H. influenzae, biofilm | N/A (neoplastic) |
| Key symptom | Globus, rawness, postnasal drip | Halitosis, tonsilliths, sore throat | Mouth breathing, snoring, OME | Cervical mass, dysphagia, otalgia |
| Treatment | Eliminate irritants, PPI for LPR | Long-term antibiotics → tonsillectomy | Adenoidectomy | Surgery, RT, chemoRT, immunotherapy |